Researchers at the University of California, San Francisco report that a novel osteoporosis prevention drug, called raloxifene, reduced the risk of invasive breast cancer in postmenopausal women with osteoporosis by 76 percent after forty months of treatment.
Scientists at UC San Francisco, working with a new experimental model that turns yeast cells into little versions of human adrenal glands, have learned how the drug medroxyprogesterone acetate (MPA) inhibits one of the key enzymes necessary to produce steroid hormones.
Angina patients whose intense, often suffocating chest pains can not be reliably relieved by medication or invasive treatments can gain significant pain reduction from a little-used medical procedure that appears to increase heart blood supply, a new study has found.
Researchers at UC San Francisco have determined that telomerase - the enzyme brought to fame last year when scientists demonstrated that its insertion into normal cells extended the healthy life span of the cells indefinitely - can wield its power in an unexpected way.
Stanley B. Prusiner, MD, 55, today was named to receive the 1997 Nobel Prize in Physiology or Medicine for discovering and characterizing an entirely new class of proteins, called prions, which cause several rare and fatal neurodegenerative diseases.